abstract |
It describes therapeutic agents that are effective in the fundamental treatment of spinal cord injury and demyelinating diseases. Specifically, therapeutic agents for spinal cord injury and therapeutic agents for demyelinating diseases are described, each containing HGF protein as an active ingredient. |